Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
SBRT plus Maintenance Chemotherapy in Stage IV NSCLC
NCT02045446Phase 2Completed
- Sponsor
- UT Southwestern Medical Center
- Start
- Feb 2014
- Primary completion
- Feb 2022
- Countries
- 1
01
Overview
Phase 2, randomised, open-label trial in non-small cell lung cancer (NSCLC) (2 arms), sponsored by UT Southwestern Medical Center. Primary endpoint: Progression Free Survival at 5 years. Started Feb 2014; status: completed.
02
Conditions
non-small cell lung cancer (NSCLC)
Beyond the preview
Go deeper on NCT02045446.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT02045446.